Since its creation, the Méditerranée-Infection foundation has aimed at optimizing the management of infectious diseases and surveying the local and global epidemiology. This pivotal role was permitted by the development of rational sampling, point-of-care tests, and extended automation as well as new technologies, including mass spectrometry for colony identification, real-time genomics for isolate characterization, and the development of versatile and permissive culture systems. By identifying and characterizing emerging microbial pathogens, these developments provided significant breakthroughs in infectious diseases.
The main aim of clinical microbiology is the identification of bacterial, viral, fungal, and parasitic agents that cause human diseases, to enable an optimized clinical management of patients as well as to prevent infectious disease transmission [1] . Over the past 30 years, in addition to culture that remains irreplaceable in routine clinical microbiology, we have implemented many new tools, including improved sampling and culture strategies, molecular methods (polymerase chain reaction [PCR] , high-throughput genome sequencing) [2] , and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) to improve our diagnostic output. These technological advances have unveiled a much larger human-associated microbiota than was expected. Herein, we review the main progress that we have developed and/or adapted to the diagnosis of infectious diseases in our clinical microbiology laboratory, notably in the fields of syndrome-and disease-based sampling kits, new culture approaches, direct pathogen detection, point-of-care (POC) testing, and clinical isolate identification. We also propose our view of the clinical microbiology laboratory (CML) of the future.
SYNDROME-BASED SAMPLING
The number of recognized pathogens that might be producing causal effects in many types of infections have abruptly increased over the past decades. The diversity and heterogeneity of these pathogens would require multiple or extensive sampling procedures, thus reducing the time-effectiveness for diagnosis. To avoid this risk, we developed standardized kits that enabled optimized sampling and testing of panels of the most likely microorganisms. The design of each test panel is based on the prevalence of the pathogens involved in the syndrome and the use of the most efficient techniques for their identification ( Figure 1 ). In addition, each kit contains the tubes and/or vials required to collect the various types of specimens needed both for direct detection of pathogens by culture, molecular assays, and/or pathological examinations, and for indirect detection, mainly represented by serological testing. To date, we have developed syndrome-based diagnostic kits for endocarditis, pericarditis, pneumonia, diarrhea, osteomyelitis, meningitis, encephalitis, uveitis, and keratitis [3] [4] [5] [6] . By significantly reducing the delay until the final diagnosis and enabling an early adequate antimicrobial therapy, shorter hospital stay, and suppression of unjustified treatments in cases of viral infections, syndrome-based sampling is cost-effective.
CULTUROMICS AND THE RENEWAL OF CULTURE
The implementation of molecular detection methods in CMLs resulted in the idea that culture would soon be useless. However, the culture of microorganisms remains crucial for fully characterizing pathogenic isolates (also essential for epidemiological studies) and evaluating their antimicrobial susceptibility. Since 2012, we developed a culture strategy based on the diversification of all culture conditions (medium, temperature, incubation time, and atmosphere) [7, 8] . This strategy, which we named culturomics and is detailed in more depth in another article of this supplement [8] , enabled the isolation of 1057 bacterial species from the human gut using up to 212 distinct culture conditions [9] . Among these species, 299 were new species, including 67 new genera (Table 1) . Another benefit from culturomics was the demonstration of a faster growth of Mycobacterium tuberculosis on blood-enriched [10] and ascorbic acid-enriched media [11] and the culture on antioxidant-supplemented agar (ascorbic acid, glutathione, and uric acid) of anaerobic bacteria in aerobic atmosphere [12] . These culture media were standardized and implemented in the routine workflow.
IDENTIFICATION OF PAST AND PRESENT MICROORGANISMS
Classic identification methods for bacterial and fungal isolates using the classic biochemical and serological properties are time-consuming and costly. As early as in 2009, we have progressively replaced them by MALDI-TOF MS [13] . We have demonstrated that MALDI-TOF MS, by being cost-effective, reproducible, and easily integrated in the CML workflow [14] , was a major step forward in routine clinical microbiology. With free-access, downloadable databases from institutions such as ours (http://www.mediterranee-infection.com/article. php?laref=256&titre=urms-database) progressively completing commercially available ones, MALDI-TOF MS is currently able to identify most human-associated bacteria and fungi as well as archaea [15] [16] [17] . With its rapidity of identification (6-10 minutes) enabling earlier decision making regarding the prescription of antimicrobial treatment for a cost of less than €1 per isolate, MALDI-TOF MS has been adopted by many large CMLs worldwide.
There is an increasing interest in identifying past pathogens and past microbiotas [18] in the perspective of understanding microbial coevolution with human populations [19] , factors shaping the human microbiota, emergence and evolution of pathogens, and the various patterns of epidemics. Among the methods currently used for the routine detection of microbes, several have been used for the identification of past microbes, including molecular methods, culture, immunohistochemistry, and detection of specific antibodies [18] . Using the below-described "suicide PCR," and as proofs of concept, we were able to detect Bartonella quintana from human teeth from a time-remote patient (4000-years), Yersinia pestis from a medieval human tooth, and Tropheryma whipplei from Dr Whipple's 1907 patient [20] [21] [22] .
DETECTION OF ANTIBIOTIC RESISTANCE
Conventional in vitro antimicrobial susceptibility assays are time-consuming and may not be compatible with the time-optimality required for acute patient care. To accelerate this process, we have demonstrated that the PREVI Isola automated seeder system (bioMérieux, Marcy-l'Etoile, France) enables standardizing and speeding up seeding [23] , and that real-time video imaging improves reading zone diameters around antibiotic discs in terms of rapidity, sensitivity, and specificity [24] . We have also developed an online database named ARG-ANNOT that contains most relevant antibiotic resistance-coding genes [25] , and real-time PCR (RT-PCR) assays targeting the most common antibiotic resistance genes of clinical relevance such as OXA-48 [26] that codes carbapenem resistance in Enterobacteriaceae. Furthermore, we have also demonstrated the antiquity of some antibiotic-resistant genes and mechanisms, showing that antibiotic resistance is partially independent from antibiotic prescription [18] . In parallel, we have adapted MALDI-TOF MS to the detection of β-lactamases and aminoglycoside-modifying enzymes such as extended-spectrum β-lactamases and ArmA methyltransferase [27] . 
IN SITU DETECTION IDENTIFICATION OF PATHOGENS

Mass Spectrometry
In addition to the primary use in the identification of bacteria from colonies, we have discovered that MALDI-TOF MS was able to detect pathogens directly within clinical samples, notably blood culture vials [28] . In the first study that we conducted on bacteria grown from blood collected in culture bottles, we were able to identify blood-borne bacteria in <2 hours with a success rate of 97.5% [28] . We and another team later adapted MALDI-TOF MS to the identification of bacteria in urine specimens [29] .
Molecular Detection
Rapid detection and identification of infectious agents in clinical specimens are mandatory to implement appropriate therapeutic measures. Having implemented the broad-range 16S ribosomal RNA (rRNA)-based PCR assay in routine diagnosis as early as 1992 [30] , we took advantage of the genome sequences that are increasingly available to develop, over the years, many species-specific PCR and RT-PCR assays that are either used individually or on a syndrome-based basis [6] , including in POC laboratories [31] . We demonstrated that targeted RT-PCR and conventional broad-range 16S rRNA PCR were complementary in the syndrome-driven diagnosis of infectious diseases [32] . In addition, we designed PCR assays with increased sensitivity, either by selecting a gene or fragment of noncoding DNA present as several copies in the genome [33] or by designing nested PCR assays targeting previously unused genomic fragments [34] . Fenollar et al identified a 7-copy fragment in the genome of T. whipplei and demonstrated that a RT-PCR assay targeting this repeated fragment was significantly more sensitive than assays targeting a single-copy fragment [33] . Targeting multicopy fragments was later demonstrated to be also highly sensitive in the detection of brucellosis, Q fever, and infections caused by Mycoplasma pneumoniae or Neisseria meningitidis. In contrast, Drancourt et al developed a strategy named "suicide PCR" that is based on nested-PCR assays targeting genome fragments that had never been used as PCR targets previously and that will be targeted only once with single-use primers [34] . These authors showed that their method was significantly more sensitive than regular PCR to detect Rickettsia species in various arthropod-borne diseases and Y. pestis in dental samples from ancient plague outbreaks [34, 35] .
Fluorescence In Situ Hybridization
As examples of fluorescence in situ hybridization (FISH) performance in our laboratory, we demonstrated the presence of Akkermansia muciniphila as part of the intestinal flora of patients without any gastrointestinal disorder [36] , the role of a new, Marseillevirus-like virus in the blood of blood donors [37] , the causative role of Marseillevirus in a lymphadenitis of a child [38] and of a woman with Hodgkin lymphoma [39] , and of Coxiella burnetii in B-cell non-Hodgkin lymphoma [40] . Such observations suggest that FISH should be considered among the diagnostic tools of advanced clinical microbiology laboratories.
GENOTYPING
Understanding precisely the source and spread of microorganisms is required in the study of outbreaks and endemic infections, and when facing the emergence of a novel pathogen or the transmission and circulation of a hypervirulent strain. Rather than using multilocus sequence typing (MLST), commonly used to characterize strains using a combination of housekeeping genes [41] , we designed the multispacer typing (MST) that combines sequences from the most variable intergenic spacers between aligned genomes of bacterial strains instead of genes [42] . First developed for Y. pestis [42] , MST was also efficient for type strains from various bacteria including C. burnetii, Rickettsia conorii, Rickettsia prowazekii, and T. whipplei [43] [44] [45] [46] . MST was demonstrated to be more discriminatory than MLST for R. conorii strains [44] . However, bacterial whole-genome sequencing using next-generation sequencing (NGS), by giving access to the whole genetic content of a strain, is the ultimate discriminatory sequence-based genotyping method and has already demonstrated its usefulness in epidemiological investigations, showing the rapid global transmission of infectious diseases [47] .We have used rapid genome sequencing, also named real-time genome sequencing, to investigate unusual cases of Staphylococcus epidermidis community-acquired endocarditis and Listeria ivanovii aortic infection [48, 49] .
GENOMICS
The development of NGS bench-top sequencers such as the MiSeq (Illumina) and Ion Torrent Personal Genome Sequencer (Life Technologies) has made genome sequencing compatible with the routine CML workflow [50] . Genome sequencing may have a number of applications including the development of molecular detection, identification and genotyping tools, of specific culture media, serological tools, monoclonal antibodies, and vaccine design [51] . In addition, within a few hours and for less than €100, exhaustive access to the deep characterization and phylogeny, virulence markers, and antibiotic resistance repertoire may be obtained for a strain of interest [51] . Using NGS, we have developed novel molecular detection, identification, and genotyping tools and investigated unusual clinical isolates as described above. In addition, we have tailored specific culture media for fastidious bacteria such as T. whipplei and for anaerobes [12, 52] . This was achieved by supplementing culture media with components that the studied bacteria were unable to synthesize due to missing or incomplete metabolic pathways, as identified in their genomes [12, 52] . Finally, we have designed a new taxonomic strategy to describe novel human-associated bacterial species isolated using culturomics. The strategy includes the systematic genome sequencing of the type strains of all new species [53] . To date, we have sequenced the genomes of the 299 new bacterial species that we have isolated.
POINT-OF-CARE LABORATORIES
Working around the clock, POC laboratories considerably reduced the turnaround time by performing mostly agglutination or immunochromatographic assays for which the results are available in <1 hour [54] , as well as RT-PCR assays that made possible the rapid molecular detection of many pathogens in emergency circumstances such as meningitis. POC assays are selected to provide an answer to the following questions having a clear impact on patient management: Is hospitalization, isolation in case of contagious risk, or onset of specific anti-infective therapy necessary? A large variety of agents can be tested, including bacteria, parasites, or viruses [54] . In a recent study, Sokhna et al described the use of a syndrome-driven strategy for the POC diagnosis of febrile illness [55] . This type of diagnostic method has the advantage of testing, in a short time and for a limited number of specimens, the most common causative agents of a given syndrome and may be especially valuable, for example, for the diagnosis of meningitis, pneumonia, endocarditis, pericarditis or sexually transmitted diseases. Finally, POC laboratories are easily implementable in any environment and may thus be established in remote areas, as we have done in rural Senegal [55] or on a commercial ship [56] .
AUTOMATED SURVEILLANCE
At the source of microbial diagnosis-produced information, CMLs have the possibility to survey the emergence of unusual phenomena such as clinical syndromes or specific microorganisms on the basis of an abnormal increase in received specimens (cerebrospinal fluid, stool, oropharyngeal swabs, etc) and/or identified pathogenic species [57] , In our laboratory, we have automated this surveillance through the creation of several software programs including EPIMIC (Epidemiological surveillance and alert based on microbiological data) [58] , BALYSES (Bacterial real-time laboratory-based surveillance system) [59] , and MARSS (Marseille antibiotic resistance surveillance system) [59] for the real-time systematic automated surveillance of infectious diseases, the number of infected patients with bacterial species isolated at least once in our CML, and resistance to antibiotics of the 15 selected bacterial species, respectively. These surveillance systems have detected an increase in urinary tract infections caused by intrinsically colistin-resistant bacteria [60] and a significant decrease in Streptococcus pneumoniae infections [61] in Marseille public hospitals, as well as rare cases of Flacklamia hominis, Vagococcus lutrae, and Sporolactobacillus laevolacticus infections [62] [63] [64] . Our system has also been able to alert regional health authorities of the early detection of a Clostridium difficile 027 outbreak in Marseille, France, allowing the implementation of specific control and therapeutic measures [65, 66] .
CONCLUSIONS
The development of -omics technologies and the centralization of biomedical analysis led to a complete reorganization of CMLs to improve the laboratory workflow and reduce the delay in diagnosis. Consequently, CMLs have become major actors in the optimization of patient management, contributing to reduce hospitalization costs [59] . In addition, CMLs are able to play a key role in detecting emerging infections, in syndromic surveillance, or in outbreak detection and warning of medical authorities. Future directions of CML development include increased automation of laboratory processes, accelerated result reporting (cell phones) to clinicians in charge, and constitution of large collections of clinical specimens and strains that can be used prospectively and retrospectively to investigate emerging infections.
Notes
Supplement sponsorship. This article appears as part of the supplement "Emerging Concepts and Strategies in Clinical Microbiology and Infectious Diseases, " sponsored by IHU Méditerranée Infection.
Potential conflicts of interest. All authors: No reported conflicts.
